Hamilelikte ethinylestradiol kullanmaktan kaçınmalı mıyım? | VeriMom

What to use instead

Pregnancy-safe ingredients that serve a similar function:

Pregnancy-safe products to use instead

Products built around the safer ingredients above, scored "no known risks" or "low risk".

Mew mew tweet

100

Mew mew tweet Cedar Spruce Baking Soda Free

Avero

100

Avero Solid Deodorant

L'Occitane

100

L´Occitane Powder To-mousse Facial Exfoliator

Unknown

100

schmidts here now

Sustain Yourself

100

Sustain Yourself Natural Deodorant

Bitamin

100

Bitamin Natural Deodorant N'orange

Routine

99

Routine Sweet Jane Deodorant Jar

Laura Mercier

99

Laura Mercier Tinted Moisturizer Broad Spectrum Spf 20 - Oil Free

Avril

99

Déodorant baume

Salt of the Earth

99

Salt of the Earth Unscented Natural Refillable Roll-on Deodorant

Hamilelikte ethinylestradiol yerine kullanılabilecek güvenli alternatifler | VeriMom

İçerikler — İçerikler

Ayrıca bakın

• ethinylestradiol hamilelikte güvenli mi?
• ethinylestradiol bebekler için güvenli mi?
• ethinylestradiol için hamilelikte güvenli alternatifler nelerdir?

FAQ

ethinylestradiol hamilelikte güvenli mi?

Ethinylestradiol (CAS 57-63-6) has a harmonised CLP classification as Repr. 1B (H360—may damage fertility or the unborn child) per ECHA, which meets the criterion for h=3. It is a potent synthetic estrogen with demonstrated estrogen receptor agonism and animal data showing adverse effects on fetal growth/survival, supporting m=2. For topical cosmetic use, systemic exposure from a cosmetic formulation would be negligible/very low, so e=0 (noting ethinylestradiol is primarily used as an oral/vaginal pharmaceutical rather than a cosmetic). ([echa.europa.eu](https://echa.europa.eu/brief-profile/-/briefprofile/100.014.129?utm_source=openai))

ethinylestradiol emzirirken güvenli mi?

Harmonised classification H360 (Repr. 1B) equally flags lactation-related reproductive hazard (h=3). Mechanistically, ethinylestradiol is an estrogen receptor agonist with demonstrated endocrine activity (m=2). Human studies indicate transfer into breast milk is negligible with low‑dose combined hormonal contraceptives, so exposure via milk from typical systemic use is low but measurable (e=1); for topical cosmetic use systemic uptake would be expected to be very low. ([echa.europa.eu](https://echa.europa.eu/brief-profile/-/briefprofile/100.014.129?utm_source=openai))

ethinylestradiol bebek cildi için güvenli mi?

Hazard (H360 Repr. 1B) remains (h=3). Mechanistic evidence of estrogenic activity supports m=2. For topical cosmetic use adult dermal exposure is expected to be negligible (adult e=0); per the scoring rules, baby skin exposure is increased by +1 (e=1) because infant skin is more permeable — although ethinylestradiol is not a typical cosmetic ingredient and meaningful topical cosmetic exposure is unlikely. Animal studies show prenatal/placental effects but no infant‑specific dermal data were found. ([echa.europa.eu](https://echa.europa.eu/brief-profile/-/briefprofile/100.014.129?utm_source=openai))

VeriMom ethinylestradiol nasıl puanlıyor?

VeriMom ethinylestradiol'yi EU CosIng, ECHA sınıflandırmaları ve PubMed çalışmalarına göre 27/100 (yüksek risk) olarak puanlar.

Hamilelikte ethinylestradiol yerine neler kullanılabilir?

Benzer işlevli ve bilinen riski olmayan alternatifleri içeren listemize bakın.